ConductScience.org, home

Paper36769824

miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL.

Zhang J and 7 others. J Clin Med, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL. Papers, record 36769824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36769824

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL.
PubMed
Journal
J Clin Med
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2023-02-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang JJingyong
2Wang SShubao
3Bai YYang
4Ali AMAasi Mohammad
5Deng JJiewen
6Chen YYushi
7Fu YYonghui
8He MMing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2021-SO-105345 TALENT PROJECT OF SHENGJING HOSPITALPubMed
2020-MS-177NATURAL SCIENCE FOUNDATION OF LIAONING PROVINCE, CHINAPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129156006DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions.Nucleic Acids Res2018https://conductscience.org/library/papers/29156006PubMed
235922756MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.Mol Med2022https://conductscience.org/library/papers/35922756PubMed
336176756An overview of resistance to chemotherapy in osteosarcoma and future perspectives.Cancer Drug Resist2022https://conductscience.org/library/papers/36176756PubMed
432192573Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.Lancet Oncol2020https://conductscience.org/library/papers/32192573PubMed
532576626The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.Clin Cancer Res2020https://conductscience.org/library/papers/32576626PubMed
622475227Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.BMC Cancer2012https://conductscience.org/library/papers/22475227PubMed
734207685Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies.Cancers (Basel)2021https://conductscience.org/library/papers/34207685PubMed
819160414Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.J Cell Physiol2009https://conductscience.org/library/papers/19160414PubMed
931528224Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer.J Cancer2019https://conductscience.org/library/papers/31528224PubMed
1031572452lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network.Front Genet2019https://conductscience.org/library/papers/31572452PubMed
1135647294Silencing circular RNA-friend leukemia virus integration 1 restrained malignancy of CC cells and oxaliplatin resistance by disturbing dyskeratosis congenita 1.Open Life Sci2022https://conductscience.org/library/papers/35647294PubMed
1233922820Role of MicroRNAs in Human Osteosarcoma: Future Perspectives.Biomedicines2021https://conductscience.org/library/papers/33922820PubMed
1329118673MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene.Cancer Cell Int2017https://conductscience.org/library/papers/29118673PubMed
1435074616MiR-197-3p reduces bortezomib resistance in multiple myeloma by inhibiting IL-6 expression in a MEAF6-dependent manner.Leuk Res2022https://conductscience.org/library/papers/35074616PubMed
1533272173MicroRNAs Implications in the Onset, Diagnosis, and Prognosis of Osteosarcoma.Curr Mol Med2021https://conductscience.org/library/papers/33272173PubMed
1633536026Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via miR-197-3p/HIPK3 axis in breast cancer.World J Surg Oncol2021https://conductscience.org/library/papers/33536026PubMed
1732767242The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.Adv Exp Med Biol2020https://conductscience.org/library/papers/32767242PubMed
1814679136Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.Ann Oncol2004https://conductscience.org/library/papers/14679136PubMed
1931632022Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.Int J Nanomedicine2019https://conductscience.org/library/papers/31632022PubMed
2034818481New Horizons in the Treatment of Osteosarcoma.N Engl J Med2021https://conductscience.org/library/papers/34818481PubMed

See all 36 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42444836Proliferation of pleural mesothelioma cells is enhanced by the microRNA-197-3p activity.Front Oncol2026https://conductscience.org/library/papers/42444836PubMed
42022572Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights.Front Pharmacol2026https://conductscience.org/library/papers/42022572PubMed
41035670The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs.Front Oncol2025https://conductscience.org/library/papers/41035670PubMed
41009512Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/41009512PubMed
40504347Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma.Discov Oncol2025https://conductscience.org/library/papers/40504347PubMed
40429954The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors.Int J Mol Sci2025https://conductscience.org/library/papers/40429954PubMed
38686047Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway.Oncol Res2024https://conductscience.org/library/papers/38686047PubMed
37937197Identification of the methotrexate resistance-related diagnostic markers in osteosarcoma via adaptive total variation netNMF and multi-omics datasets.Front Genet2023https://conductscience.org/library/papers/37937197PubMed
37740818Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis.Mol Biotechnol2024https://conductscience.org/library/papers/37740818PubMed
37523046SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.J Neurooncol2023https://conductscience.org/library/papers/37523046PubMed

Download CSV of cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCA424PubTator's text mininghttps://conductscience.org/library/genes/24NCBI Gene
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ATG1083734PubTator's text mininghttps://conductscience.org/library/genes/83734NCBI Gene
ATP8A251761PubTator's text mininghttps://conductscience.org/library/genes/51761NCBI Gene
BMPR2659PubTator's text mininghttps://conductscience.org/library/genes/659NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CCS9973PubTator's text mininghttps://conductscience.org/library/genes/9973NCBI Gene
DKC11736PubTator's text mininghttps://conductscience.org/library/genes/1736NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
KIF26B55083PubTator's text mininghttps://conductscience.org/library/genes/55083NCBI Gene
KLF107071PubTator's text mininghttps://conductscience.org/library/genes/7071NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MIR17406952PubTator's text mininghttps://conductscience.org/library/genes/406952NCBI Gene
MIR197406974PubTator's text mininghttps://conductscience.org/library/genes/406974NCBI Gene
MIR1973100302290PubTator's text mininghttps://conductscience.org/library/genes/100302290NCBI Gene

See all 33 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36769824

GET https://conductscience.org/api/papers/v1/36769824/references?page=2